T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection
- PMID: 17372003
- DOI: 10.4049/jimmunol.178.7.4455
T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection
Abstract
Replication of human cytomegalovirus is controlled by a vigorous CD8 T cell response. The persistent nature of infection is believed to periodically stimulate T cell responses resulting in considerable expansions of virus-specific CD8 T cells over time. In this study, we describe the magnitude and breadth of CD8 T cell responses against the immunodominant viral Ags, IE-1 and pp65, in acute and long-term infection using the IFN-gamma ELISPOT assay. Simultaneously, we have identified several novel MHC class I restricted CD8 T cell epitopes. Acute phase responses in immunocompetent donors appear to be extremely focused as early as 1 week post diagnosis with dominant peptide-specific responses observed against both proteins. These dominant responses remain detectable at all later time points over a 4-year follow-up. Interestingly the IE-1 responses show an increase over time whereas the pp65 responses do not, which contrasts with data showing that responses against both Ags are elevated in elderly individuals. We also observe the rapid emergence of an effector memory phenotype for virus-specific CD8 T cells as observed in persistent infection. Over time the revertant CD45RA(pos) effector cell population is also expanded, and this is more evident in the preferentially expanded IE-1 responses. We postulate that periodic low-level virus reactivation after the acute infection phase preferentially stimulates these responses whereas pp65-specific T cell expansions probably occur during the infrequent episodes of lytic viral replication or secondary infection.
Similar articles
-
Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.Cytometry B Clin Cytom. 2008 Jul;74(4):211-20. doi: 10.1002/cyto.b.20420. Cytometry B Clin Cytom. 2008. PMID: 18454493
-
Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.J Immunol. 2004 Feb 15;172(4):2256-64. doi: 10.4049/jimmunol.172.4.2256. J Immunol. 2004. PMID: 14764694
-
The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.J Virol. 1996 Nov;70(11):7569-79. doi: 10.1128/JVI.70.11.7569-7579.1996. J Virol. 1996. PMID: 8892876 Free PMC article.
-
Progress made towards the development of a CMV peptide vaccine.Hum Immunol. 2004 May;65(5):544-9. doi: 10.1016/j.humimm.2004.02.005. Hum Immunol. 2004. PMID: 15172455 Review.
-
Recombinant viruses as tools to study human cytomegalovirus immune modulation.Med Microbiol Immunol. 2008 Jun;197(2):215-22. doi: 10.1007/s00430-008-0083-4. Epub 2008 Feb 27. Med Microbiol Immunol. 2008. PMID: 18301917 Review.
Cited by
-
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.Nat Immunol. 2021 Jan;22(1):74-85. doi: 10.1038/s41590-020-00808-x. Epub 2020 Sep 30. Nat Immunol. 2021. PMID: 32999467
-
Functional studies of HLA and its role in SARS-CoV-2: Stimulating T cell response and vaccine development.Life Sci. 2023 Feb 15;315:121374. doi: 10.1016/j.lfs.2023.121374. Epub 2023 Jan 6. Life Sci. 2023. PMID: 36621539 Free PMC article. Review.
-
Generation, maintenance and tissue distribution of T cell responses to human cytomegalovirus in lytic and latent infection.Med Microbiol Immunol. 2019 Aug;208(3-4):375-389. doi: 10.1007/s00430-019-00598-6. Epub 2019 Mar 20. Med Microbiol Immunol. 2019. PMID: 30895366 Free PMC article. Review.
-
MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.Blood. 2017 Jan 5;129(1):114-125. doi: 10.1182/blood-2016-07-729756. Epub 2016 Oct 19. Blood. 2017. PMID: 27760761 Free PMC article. Clinical Trial.
-
Cytomegalovirus in hematopoietic stem cell transplant recipients.Hematol Oncol Clin North Am. 2011 Feb;25(1):151-69. doi: 10.1016/j.hoc.2010.11.011. Hematol Oncol Clin North Am. 2011. PMID: 21236396 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials